Related Experiment Video

Updated: Oct 1, 2025

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

8.4K

Corrigendum: MIS-C Treatment: Is IVIG Always Necessary?

Francesco Licciardi1,2, Letizia Baldini3, Marta Dellepiane1

  • 1Department of Pediatrics and Public Health, Università degli Studi di Torino, Turin, Italy.

Frontiers in Pediatrics
|March 3, 2022
PubMed

[This corrects the article DOI: 10.3389/fped.2021.753123.].

[This corrects the article DOI: 10.3389/fped.2021.753123.].

Keywords:
IVIG (intravenous immunoglobulin) administrationMIS-CSARS-CoV-2steroidtherapy

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.9K
Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

3.4K

Related Experiment Videos

Last Updated: Oct 1, 2025

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

8.4K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.9K
Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

3.4K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.1K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

27
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
27

Articles linked to this work by shared authors, journal, and citation graph.

Epstein-Barr Virus DNA Detection Without Detectable Expression of Selected Viral Transcripts in Pediatric Patients with Systemic Lupus Erythematosus.

Genes·2026

SIRENA protocol: an Italian, prospective, multicentre cohort study of children and adults with islet autoimmunity and early-stage type 1 diabetes.

BMJ open·2026

All-in-one sensor design with overlapping sensor transition reduces automode interruptions and improves patient-reported outcomes in adolescents with type 1 diabetes: real-world evidence from simplera sync integration.

Diabetes research and clinical practice·2026

Salivary hormones and adipokines are associated with glycemic control and early renal and cardiometabolic markers in children and young adults with type 1 diabetes.

Journal of endocrinological investigation·2026

Continuous Glucose Monitoring and Automated Insulin Delivery in Infants with Type 1 Diabetes: Real-World Evidence to Support Future International Guidelines.

Diabetes technology & therapeutics·2026

Genetic susceptibility to thrombotic microangiopathy in a 10-month-old patient with SMA type 1: a caveat for gene therapy eligibility.

Neuromuscular disorders : NMD·2026

The relationship between preoperative anxiety and acute pain and nausea-vomiting in children after surgery.

Frontiers in pediatrics·2026

Intraoperative traction in posterior spinal fusion for adolescent idiopathic scoliosis: an updated systematic review and meta-analysis of correction, perioperative, and safety outcomes.

Frontiers in pediatrics·2026

High-frequency percussive ventilation in pediatric acute respiratory failure in a community-based pediatric intensive care unit.

Frontiers in pediatrics·2026

Peripheral manifestations of monocarboxylate transporter 8 deficiency: hepatic and skeletal muscle involvement.

Frontiers in pediatrics·2026

Associations between fat-soluble vitamin status, growth, and development in Chinese children aged 3-14 years: a cross-sectional study.

Frontiers in pediatrics·2026

Correction: Interleukin-6 in complications of prematurity: from biomarker to targeted therapy.

Frontiers in pediatrics·2026

Immediate Neoumbilicoplasty Following Excision of a Symptomatic Umbilical Lipoma Using Local Tissue Rearrangement and Fascial Fixation: A Case Report.

Cureus·2026

Quercetin-loaded exosomes prevent endometrial fibrosis by downregulating EGFR.

International immunopharmacology·2026

Mapping immune cell metabolic reprogramming from mechanistic hotspots to translational directions: A bibliometric analysis with exploratory clinical evidence.

Human immunology·2026

A triple-immunomodulatory quercetin nanoplatform to reinforce T-cell function and remodel tumor microenvironment.

Biomaterials advances·2026

Antigen-specific regulatory T cells eliminate cognate CD4 effector T cells through perforin, granzyme B, and Bim.

Cell reports·2026

Mechanism of SGLT2 inhibitors in improving immune imbalance in diabetic mice with sepsis via regulating macrophage M2 polarization through the APOC1/HMGB1/TLR4 axis.

Journal of immunology (Baltimore, Md. : 1950)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us